Tumor gene signature associated with neurotoxicity in R/R B-ALL patients treated with JCAR015, a CD19-directed CAR T cell product.

7007Background: CD19-directed chimeric antigen receptor modified T (CAR T) cells produce therapeutic responses in adult R/R B-ALL. However, CAR T therapy is also associated with serious toxicities ...